Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.09%8.42B | -3.57%8.41B | 1.39%2.2B | -4.62%2.13B | -4.84%2.04B | -6.17%2.05B | -2.72%8.73B | -7.02%2.17B | -3.49%2.23B | -2.64%2.15B |
| Cost of revenue | 0.92%7.8B | -4.49%7.73B | -0.89%2B | -7.01%1.97B | -3.86%1.89B | -6.09%1.87B | -1.74%8.09B | -5.68%2.02B | 0.40%2.11B | -3.28%1.97B |
| Gross profit | -9.27%624.43M | 8.14%688.26M | 32.46%196.24M | 38.64%162.12M | -15.56%151.45M | -7.05%178.46M | -13.69%636.42M | -22.16%148.15M | -43.25%116.93M | 4.94%179.35M |
| Operating expense | -7.29%607.51M | 4.00%655.28M | 0.09%157.2M | -1.85%173.74M | 10.86%160.71M | 8.32%163.63M | 7.53%630.1M | 5.45%157.06M | 17.19%177.01M | 2.66%144.97M |
| Selling and administrative expenses | -7.29%607.51M | 4.00%655.28M | 0.09%157.2M | -1.85%173.74M | 10.86%160.71M | 8.32%163.63M | 7.53%630.1M | 5.45%157.06M | 17.19%177.01M | 2.66%144.97M |
| -Selling and marketing expense | -2.66%22.35M | -13.32%22.96M | -18.05%5.59M | -21.60%5.61M | -21.87%5.71M | 16.20%6.06M | 21.65%26.49M | 23.32%6.82M | 34.43%7.15M | 38.77%7.3M |
| -General and administrative expense | -7.46%585.16M | 4.76%632.33M | 0.91%151.61M | -1.01%168.14M | 12.59%155.01M | 8.04%157.57M | 6.99%603.62M | 4.76%150.24M | 16.56%169.86M | 1.27%137.67M |
| Operating profit | -48.69%16.92M | 421.72%32.97M | 538.32%39.04M | 80.65%-11.63M | -126.96%-9.27M | -63.77%14.83M | -95.83%6.32M | -121.52%-8.91M | -209.23%-60.08M | 15.79%34.37M |
| Net non-operating interest income (expenses) | -54.73%-22.64M | 8.39%-14.63M | -19.35%-4.33M | -0.47%-3.82M | 15.18%-3.6M | 32.90%-2.89M | 9.88%-15.97M | 12.92%-3.63M | 13.90%-3.8M | 5.16%-4.24M |
| Non-operating interest income | 130.23%396K | 8,500.00%172K | --2K | --0 | -50.00%1K | --169K | -98.84%2K | --0 | --0 | 100.00%2K |
| Non-operating interest expense | 55.61%23.03M | -7.32%14.8M | 19.41%4.33M | 0.47%3.82M | -15.19%3.6M | -28.97%3.06M | -10.74%15.97M | -16.31%3.63M | -13.92%3.8M | -5.14%4.25M |
| Net investment income | 18.62%65.02M | 11.60%54.81M | -28.20%191K | 5.56%28.93M | 3.00%309K | 20.07%25.38M | 23.11%49.11M | 22.02%266K | 48.99%27.41M | 4.53%300K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 27.9M | 0 | ||||||||
| Income from associates and other participating interests | 262.50%21.4M | -43.81%5.9M | 162.10%2.47M | -102.11%-78K | -11.76%3.46M | -97.27%53K | 320.28%10.51M | 181.21%942K | -4.59%3.7M | 107.90%3.92M |
| Special income (charges) | 121.27%5.41M | -2,504.73%-25.42M | -98.40%-12.31M | -732.73%-18.52M | 49.41%3.14M | 1.75%2.27M | 101.82%1.06M | -551.00%-6.2M | 12,826.09%2.93M | 112.01%2.1M |
| Less:Other special charges | -121.27%-5.41M | 2,504.73%25.42M | 98.40%12.31M | 732.73%18.52M | -49.41%-3.14M | -1.75%-2.27M | -101.82%-1.06M | 551.00%6.2M | -12,826.09%-2.93M | -112.01%-2.1M |
| Other non-operating income (expenses) | -48.21%17.76M | -9.95%34.3M | 6.67%20.28M | -48.09%6.56M | 126.60%3.85M | -23.92%3.6M | 39.44%38.09M | 238.78%19.02M | 17.70%12.64M | -62.58%1.7M |
| Income before tax | 49.85%131.78M | -1.32%87.94M | 2,949.29%45.34M | 108.41%1.45M | -105.52%-2.11M | -35.13%43.26M | -60.37%89.12M | -96.37%1.49M | -120.59%-17.21M | 15.90%38.15M |
| Income tax | 2.71%28.01M | -1.22%27.27M | 1,284.39%13.48M | 5.41%-6.33M | -64.53%4.07M | -26.59%16.04M | -60.80%27.6M | -91.89%974K | -126.00%-6.69M | 10.14%11.47M |
| Net income | 71.03%103.77M | -1.37%60.67M | 6,110.33%31.86M | 173.88%7.77M | -123.14%-6.18M | -39.30%27.22M | -60.17%61.52M | -98.23%513K | -118.18%-10.52M | 18.57%26.68M |
| Net income continuous operations | 71.03%103.77M | -1.37%60.67M | 6,110.33%31.86M | 173.88%7.77M | -123.14%-6.18M | -39.30%27.22M | -60.17%61.52M | -98.23%513K | -118.18%-10.52M | 18.57%26.68M |
| Noncontrolling interests | -109.43%-60K | 253.25%636K | 324.44%505K | 796.30%188K | -38.89%-200K | 852.63%143K | -129.20%-415K | -142.13%-225K | -102.31%-27K | -550.00%-144K |
| Net income attributable to the company | 72.94%103.83M | -3.06%60.04M | 4,148.51%31.35M | 172.28%7.58M | -122.27%-5.98M | -39.64%27.08M | -59.52%61.93M | -97.40%738K | -118.51%-10.49M | 19.38%26.83M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 72.94%103.83M | -3.06%60.04M | 4,148.51%31.35M | 172.28%7.58M | -122.27%-5.98M | -39.64%27.08M | -59.52%61.93M | -97.40%738K | -118.51%-10.49M | 19.38%26.83M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 78.42%35.38 | -2.22%19.83 | 4,233.33%10.4 | 173.26%2.52 | -122.30%-1.96 | -39.62%8.87 | -59.53%20.28 | -97.42%0.24 | -118.53%-3.44 | 19.43%8.79 |
| Diluted earnings per share | 78.42%35.38 | -2.22%19.83 | 4,233.33%10.4 | 173.26%2.52 | -122.31%-1.96 | -39.62%8.87 | -59.53%20.28 | -97.42%0.24 | -118.53%-3.44 | 19.38%8.7861 |
| Dividend per share | 0.00%10 | 0.00%10 | 0.00%10 | 0 | 0 | 0 | 0.00%10 | 0.00%10 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |